Northrop Grumman Q3: Record Backlog and Big Wins, But Margin and Program Woes
Record Backlog and Raised Guidance Northrop's backlog hit a record ~$105 billion, and the company raised its 2026 guidance. This signals strong demand for its defense products and supports future revenue growth, boosting investor confidence.
This point highlights the core positive driver of demand and financial health that lifted the stock.
Major Contract Wins and International Interest Northrop won over $6 billion in new awards, including $3 billion+ in missile-defense deals, and saw ~$50 billion in NATO interest. Progress on Sentinel and the now-profitable B-21 also supports growth.
This point shows tangible new business and program milestones that drive revenue and sentiment.
Margin Pressure and EPS Decline Operating margin fell to 10.1%, and EPS is expected to shrink 7.7%. Program charges, F-35 overruns, and losing the $20 billion F/A-XX contest hurt sentiment, raising concerns about profitability.
This point captures the key negative factors that weighed on the stock price.
Sentinel Cost Overrun and Analyst Downgrade Sentinel's 81% cost overrun triggered a Nunn-McCurdy breach, and B-21 carries ~$2 billion in charges. Barclays initiated coverage at Underweight, citing slow 2.6% growth, adding to negative pressure.
This point highlights specific program risks and analyst skepticism that contributed to downside.
